Page last updated: 2024-09-25

muricholic acid

Description

muricholic acid: internal standard in analysis of fecal bile acids; RN given refers to (3 alpha,5 beta)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID119473
CHEBI ID134216
MeSH IDM0046016

Synonyms (16)

Synonym
muricholic acid
3,6,7-trihydroxy-5-cholanoic acid
39016-49-4
CHEBI:134216
(4r)-4-[(3r,5r,8s,9s,10r,13r,14s,17r)-3,6,7-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoic acid
trihydroxy-5alpha-cholanoic acid
3alpha,6alpha,7beta-trihydroxy-5beta-cholanoic acid
cholan-24-oic acid, 3,6,7-trihydroxy-, (3alpha,5beta)-
muricholate
3alpha,6,7-trihydroxy-5beta-cholanic acid
trihydroxy-5alpha-cholanoate
3,6,7-trihydroxy-5-cholanoate
3alpha,6alpha,7beta-trihydroxy-5beta-cholanoate
(3alpha,5beta)-3,6,7-trihydroxy-cholan-24-oic acid
(3alpha,5beta)-3,6,7-trihydroxy-cholan-24-oate
DTXSID901317089

Drug Classes (6)

ClassDescription
3alpha-hydroxy steroidA 3-hydroxy steroid in which the 3-hydroxy substituent is in the alpha-position.
bile acidAny member of a group of hydroxy-5beta-cholanic acids occuring in bile, where they are present as the sodium salts of their amides with glycine or taurine. In mammals bile acids almost invariably have 5beta-configuration.
6-hydroxy steroid
7-hydroxy steroidA hydroxy steroid carrying a hydroxy substituent at position 7.
trihydroxy-5beta-cholanic acid
C24-steroidA steroid compound with a structure based on a 24-carbon (cholane) skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (117)

TimeframeStudies, This Drug (%)All Drugs %
pre-199035 (29.91)18.7374
1990's33 (28.21)18.2507
2000's13 (11.11)29.6817
2010's22 (18.80)24.3611
2020's14 (11.97)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.84%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (0.84%)4.05%
Observational1 (0.84%)0.25%
Other116 (97.48%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research Highlights

Pharmacokinetics (1)

ArticleYear
An HPLC-MS/MS method for quantitation of Gly-MCA in mouse plasma: Application to a pharmacokinetic study.
Journal of pharmaceutical and biomedical analysis, Nov-30, Volume: 146
2017
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Dosage (2)

ArticleYear
Increased bile acids in enterohepatic circulation by short-term calorie restriction in male mice.
Toxicology and applied pharmacology, Dec-15, Volume: 273, Issue: 3
2013
Role of hydrophilic bile acids and of sterols on cholelithiasis in the hamster.
Journal of lipid research, Volume: 25, Issue: 6
1984
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]